Marietta Eye Clinic

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Diabetic eye disease4 trials
• Macular degeneration3 trials

Phase

• Phase 23 trials
• Phase 32 trials
• Phase 2/31 trial
• Phase 41 trial

Status

• Completed5 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Greater Houston Retina Research1 trial
• Jaeb Center for Health Research1 trial
• Oculis1 trial
• Oxurion1 trial
• and 1 more

Running trials

• Recruiting

  A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT06635148· Phase 2/3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Fenofibrate for Prevention of DR Worsening

  NCT04661358· Phase 3· Jaeb Center for Health Research· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration1 recruiting

Closed trials

• Completed

  A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)

  NCT06172257· Phase 3· Oculis· Source

• Completed

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  QA102 Phase II Study in Subjects With Dry AMD

  NCT05536752· Phase 2· Smilebiotek Zhuhai Limited· Source

• Completed

  Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial

  NCT04708145· Phase 4· Greater Houston Retina Research· Source

• Completed

  A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

  NCT04527107· Phase 2· Oxurion· Source